Brendan O’Leary, B.S.

Deputy Director
Food and Drug Administration

Disclosure: No financial relationships or conflicts of interest

Presentation(s):

• LB-15 - A Trans-Governmental Collaborative Effort to Independently Evaluate SARS-CoV-2 Serology Assays Using Well-Characterized Sample Panels

  Saturday, October 24, 2020
  2:15pm – 2:25pm EDT